Literature DB >> 1629626

Human skin mast cell carboxypeptidase: functional characterization, cDNA cloning, and genealogy.

M Natsuaki1, C B Stewart, P Vanderslice, L B Schwartz, M Natsuaki1, B U Wintroub, W J Rutter, S M Goldstein.   

Abstract

We functionally characterized human skin mast cell carboxypeptidase A (MC-CPA), and explored its evolutionary relationship to other carboxypeptidases to understand further the structural basis for the substrate preferences of this enzyme. Purified human skin MC-CPA displayed more activity than did bovine pancreatic carboxypeptidase A (CPA) against carboxyl-terminal leucine residues, about equal activity with phenylalanine and tyrosine residues, and no activity with tryptophan or alanine. To correlate kinetic data with structure, we isolated and sequenced a cDNA encoding MC-CPA from human skin, and directly sequenced 30% of the purified protein. These sequences agreed with that of human lung MC-CPA, and further support the evidence for a single MC-CPA gene in humans. Four amino acid replacements, resulting in a net positive change in non-hydrogen atoms in the S1' subsite of MC-CPA, were associated with less alteration in substrate specificity, relative to bovine CPA, than might be expected from studies using rat CPA1 and CPA2. We noted two consensus N-linked glycosylation sites in human MC-CPA that are not found in rat and mouse MC-CPA, or in bovine CPA; that at least one of these sites is glycosylated in vivo was verified by N-glycosidase F treatment, lentil lectin binding, and Concanavalin A-Sepharose chromatography. Evolutionary trees constructed from the known carboxypeptidase sequences suggested that MC-CPA most likely evolved from a carboxypeptidase B-like enzyme, independent of the pancreatic CPA. Thus, in the carboxypeptidase gene family, MC-CPA displays a unique genealogy and several amino acid replacements in its S1' binding pocket that result in substrate specificity quite similar to bovine CPA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629626     DOI: 10.1111/1523-1747.ep12616776

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Substrate specificity of human carboxypeptidase A6.

Authors:  Peter J Lyons; Lloyd D Fricker
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

Review 2.  Active monomers of human beta-tryptase have expanded substrate specificities.

Authors:  Yoshihiro Fukuoka; Lawrence B Schwartz
Journal:  Int Immunopharmacol       Date:  2007-07-27       Impact factor: 4.932

3.  Cloning and expression of human colon mast cell carboxypeptidase.

Authors:  Zhang-Quan Chen; Shao-Heng He
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 4.  Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells.

Authors:  Dmitri Atiakshin; Andrey Kostin; Ivan Trotsenko; Vera Samoilova; Igor Buchwalow; Markus Tiemann
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

5.  Peripheral blood RNA gene expression profiling in patients with bacterial meningitis.

Authors:  Margit Lill; Sulev Kõks; Ursel Soomets; Leonard C Schalkwyk; Cathy Fernandes; Irja Lutsar; Pille Taba
Journal:  Front Neurosci       Date:  2013-03-18       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.